Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease
Windisch, Paul; Guckenberger, Matthias (2019). Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease. Journal of Thoracic Disease, 11(S15):S1869-S1873.
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Pulmonary and Respiratory Medicine |
| Uncontrolled Keywords: | Pulmonary and Respiratory Medicine |
| Language: | English |
| Date: | 1 September 2019 |
| Deposited On: | 04 Feb 2020 16:04 |
| Last Modified: | 04 Sep 2024 03:41 |
| Publisher: | AME Publishing Company |
| ISSN: | 2072-1439 |
| OA Status: | Gold |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.21037/jtd.2019.08.123 |
Permanent URL
https://doi.org/10.5167/uzh-181415
Download
Preview
- Content: Published Version
- Language: English
- Licence:
Links
Statistics
Citations
Dimensions.ai Metrics
Windisch, Paul